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Abstract
Background: Cissus sicyoides (Vitaceae) is a medicinal plant popularly known in Brazil as "cipó-
pucá, anil-trepador, cortina, and insulina". The plant is used in several diseases, including
rheumatism, epilepsy, stroke and also in the treatment of diabetes. In the present work, we studied
the hypoglycemic and anti-lipemic effects of the aqueous extract prepared from fresh leaves of the
plant (AECS), in the model of alloxan-induced diabetes in rats. In addition, hepatic enzyme levels
were also determined.
Results: Results showed that the daily treatment of diabetic rats with AECS for 7 days (100 and
200 mg/kg, p.o.) significantly decreased blood glucose levels in 25 and 22% respectively, as
compared to the same groups before AECS treatment. No significant changes were seen in control
diabetic rats before (48 h after alloxan administration) and after distilled water treatment. While
no changes were seen in total cholesterol levels, a significant decrease was observed in plasma
triglyceride levels, in the alloxan-induced diabetic rats after AECS treatment with both doses, as
compared to the same groups before treatment. Significant decreases in blood glucose (25%) and
triglyceride levels (48%) were also observed in the alloxan-induced diabetic rats after 4 days
treatment with AECS (200 mg/kg, p.o.). Aspartate (AST) and alanine (ALT) aminotransferases
levels, in diabetic controls and AECS-treated rats, were in the range of reference values presented
by normal rats.
Conclusions: The results justify the popular use of C. sicyoides, pointing out to the potential benefit
of the plant aqueous extract (AECS) in alternative medicine, in the treatment of type 2 diabetes
mellitus.
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Background
There are several species of medicinal plants popularly
used in the treatment of diabetes mellitus, a disease
responsible for serious complications, affecting a large
number of people worldwide. Cissus sicyoides (L.) belongs
to the Vitaceae family, and is a medicinal plant popularly
used in Brazil in several diseases, such as epilepsy, stroke,
as well as in abscesses and in the treatment of diabetes.
Anti-inflammatory and anti-rheumatic activities are also
attributed to the plant. Other species (C. succicaulis) pre-
sented anti-ulcer activity in the model of ethanol-induced
gastric ulcer in rats [1]. A survey carried out in Nigeria
identified  C. populnea, among other species, as being
largely used for the treatment of trypanosomiasis [2]. The
aqueous extract from C. rubiginosa was shown to possess
prominent antibacterial activity, which supports the
ethno-medical use of this plant as an anti-diarrhea agent
[3].
Earlier work [4] showed that the aqueous extract from C.
sicyoides  contracts isolated guinea pig aortic rings, in a
dose dependent manner. These authors concluded that
the extract acts at the membrane level, increasing the cal-
cium entry through the membrane as well as acting in the
internal calcium deposits, such as the sarcoplasmic reticu-
lum. In a recent work [5], the aqueous extract from C. sicy-
oides was shown to present an anti-inflammatory effect, as
determined by the carrageenan-induced rat paw edema (a
model for general inflammation), and in the mouse ear
edema (a model of topical inflammation). These authors
also observed a decrease in the level of myeloperoxidase
in tissue samples from the inflammation area. While
Saenz et al. [6] demonstrated a cytostatic activity in C. sicy-
oides against Hep-cells, others [7] did not detect any anti-
viral activity against the influenza type A virus, in this spe-
cies. According to these authors, the main chemical com-
ponents of the aerial part of C. sicyoides were tannins,
steroid-triterpenes, aminoacids, lipids and flavonoids.
Another phytochemical analysis of the plant showed the
presence of alkaloids, triterpenes and/or steroids, flavo-
noids, tannins and saponins [3]. Other compounds,
namely onocer-7-ene 3 alpha 21 beta-diol, delta-amyrin,
delta-amyrone, and 3,3', 4,4'-tetrahydroxybiphenyl were
also isolated from C. quadrangularis. These compounds
are used for plant extract standardization purposes [8]. An
earlier study [9] detected the presence of steroids, terpe-
nes, quinones and phenolic compounds in C. sicyoides,
while others showed no alkaloid in the plant, and cyani-
dins only in the fruit [10,11]. Recently [12,13], a new cou-
marin glycoside, 5,6,7,8 tetrahydroxycoumarin-5-beta-
xylo-pyranoside was isolated from the aerial parts of C.
sicyoides, together with a known coumarin, sabadin, two
flavonoids, kaempferol 3-rhamnoside and quercetin 3-
rhamnoside, and two steroids, sitosterol and 3-beta-O-
beta-glupyranosylsitosterol.
We showed [14,15] that the aqueous extract from C. sicy-
oides (AECS) presents an anti-nociceptive activity, as dem-
onstrated by the tests of acetic acid-induced abdominal
contractions, formalin, and hot plate in mice. Besides,
AECS also has anticonvulsant properties as evidenced in
the models of pentylenetetrazol and strychnine-induced
convulsions in mice. Although the plant is popularly
used, in Brazil, for the treatment of diabetes mellitus,
there are only two reports in the literature on this subject
[16,17]. Furthermore, several plant constituents, includ-
ing flavonoids (also detected in AECS), are known to
decrease triglycerides and transaminases [18,19], which
are usually increased in the serum of diabetic patients
[20]. Thus, in order to validate the popular use of the
plant as an anti-diabetic, the objectives of the present
work were to study the possible effects of the aqueous
extract from leaves of C. sicyoides on glycemia, lipid pro-
file, as well as on levels of ALT and AST hepatic enzymes,
in the model of alloxan-induced diabetes, in rats.
Results
Table 1 shows the results of blood glucose values in
alloxan-induced diabetic rats, after the daily treatment
with the aqueous extract of C. sicyoides (AECS 100 and 200
mg/kg, p.o.), for 7 days. Significant decreases in the blood
glucose levels, of 25 and 22% respectively, were observed
in the groups treated with both doses of AECS, as com-
pared to the same group before treatment. No significant
changes were seen in diabetic (48 h after administration
with alloxan) controls, before and after distilled water
treatment.
While no changes were seen in total cholesterol levels in
any group (AECS treated and controls), a significant
decrease was observed in plasma triglyceride levels in the
alloxan-induced diabetic rats, after AECS treatment for 7
days with the doses of 100 mg/kg (50% decrease) and 200
mg/kg (42% decrease) (Table 2).
Table 3 shows the results of AECS (100 and 200 mg/kg)
treatments, for 4 days, on biochemical parameters in the
blood of alloxan-induced diabetic rats. Even after this
shorter treatment, there was a significant decrease (25%)
in the blood glucose levels after treatment with the higher
AECS dose. AST and ALT levels were also significantly
increased after distilled water and with the lower (100
mg/kg), but not with the higher dose of AECS (200 mg/
kg). However, these enzyme alterations are still in the
range of reference values shown in Table 6. Although trig-
lyceride levels were significantly decreased after 4-day
treatment in the three groups, the decrease was muchBMC Pharmacology 2004, 4 http://www.biomedcentral.com/1471-2210/4/9
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higher (48%) in the diabetic rats after AECS (100 and 200
mg/kg) treatments, as compared to diabetic control rats
(27%) at the same period of time (Table 3).
Under the conditions of the present work, the alloxan
treatment (60 mg/kg) caused a 22% body weight loss,
after 7 days, while in the alloxan plus AECS-treated group
the body weight decrease ranged from 8.5 to 14%. The
percentage death was between 33 and 53%, at the same
period of time (Table 4). On the other hand, AECS alone
and in the absence of alloxan did not alter the biochemi-
cal profile of the parameters studied when administered
Table 1: Effects of the aqueous extract from leaves of Cissus sicyoides (AECS) on blood glucose levels in alloxan-induced diabetic rats
Group Glucose levels (mg/dL)
(Before treatment) (After treatment)
Control (11) 313.1 ± 15.04 281.0 ± 15.07
AECS
100 mg/kg, p.o. (20) 300.1 ± 10.47 224.7 ± 13.13*
200 mg/kg, p.o. (13) 292.7 ± 8.05 227.8 ± 12.90*
Values are means ± SEM of the number of animals (in parenthesis). The blood was collected from the orbital sinus, 48 h after alloxan administration, 
60 mg/kg, i.v., before and 1 h after the last administration of distilled water (control group) or of AECS, administered daily for 7 days. *p < 0.05 as 
compared to the same group, 48 h after alloxan administration (ANOVA and Tukey as the post hoc test).
Table 2: Effects of the aqueous extract from Cissus sicyoides (AECS) on blood total cholesterol and triglyceride levels in alloxan-induced 
diabetic rats
Group Cholesterol (mg/dL) Before Cholesterol (mg/dL) After Triglycerides (mg/dL) Before Triglycerides (mg/dL) After
Control (7) 87.0 ± 5.15 74.0 ± 2.93 244.0 ± 29.65 286.8 ± 58.23
AECS
100 mg/kg, p.o. (20) 76. 8 ± 3.94 78.1 ± 5.18 222.1 ± 26.40 111.5 ± 9.51*
200 mg/kg, p.o. (13) 86.4 ± 2.96 73.2 ± 3.27 294.0 ± 32.89 171.1 ± 19.13*
Values are means ± SEM of the number of animals (in parenthesis). The blood was collected from the orbital sinus, 48 h after alloxan administration, 
60 mg/kg, i.v., before and 1 h after the last administration of distilled water (control group) or AECS, administered daily for 7 days. *p < 0.05 as 
compared to the same group, 48 h after alloxan injection (ANOVA and Tukey as the post hoc test).
Table 3: Effects of the aqueous extract from Cissus sicyoides (AECS) on biochemical parameters in the blood from alloxan-induced 
diabetic rats
Parameter Group
Control AECS 100 mg/kg AECS 200 mg/kg
Glucose (mg/dL)
Before 264.8 ± 12.66 252.2 ± 8.44 250.8 ± 10.74
After 248.1 ± 11.65 218.1 ± 16. 21 188.0 ± 16.22*
Cholesterol (mg/dL)
Before 58.4 ± 3.92 56.6 ± 3.19 63.0 ± 2.55
After 55.4 ± 2.91 50.1 ± 5.89 54.6 ± 2.29
Triglycerides (mg/dL)
Before 169.8 ± 8.61 256.4 ± 24.60 165.4 ± 12.87
After 124.1 ± 8.02 * 132.5 ± 9.02 * 86.4 ± 7.56 *
ALT (IU/l)
Before 20.0 ± 1.33 28.6 ± 2.15 20.8 ± 1.62
After 34.7 ± 2.89 * 41.2 ± 2.71 * 29.8 ± 2.22
AST (IU/l)
Before 60.5 ± 3.90 62.2 ± 5.52 75.9 ± 4.74
After 85.5 ± 4.35 * 89.3 ± 7.03 * 88.3 ± 3.73
Values are means ± SEM of 8 to 18 animals per group. The blood was collected from the orbital sinus, 48 h after the alloxan administration, 60 mg/
kg, i.v., before and 1 h after the last administration of distilled water (controls) or AECS, daily for 4 days. *p < 0.05 as compared to the same group, 
48 h after the alloxan injection (ANOVA and Tukey as the post hoc test).BMC Pharmacology 2004, 4 http://www.biomedcentral.com/1471-2210/4/9
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with the dose of 100 mg/kg, p.o., daily, for 7 days, as com-
pared to reference values from normal animals (Table 5).
The phytochemical analysis of the aqueous extract pre-
pared from the fresh leaves of C. sicyoides revealed the
presence of flavonoids and hydrolyzable tannins, and the
absence of coumarin, anthraquinones, alkaloids, sapon-
ins and steroids (Table 6).
Discussion
In the present work, we investigated the hypoglycemic
and anti-lipemic effects of the aqueous extract from C.
sicyoides in the model of alloxan-induced diabetes in rats.
Alloxan causes diabetes through its ability to destroy the
insulin-producing beta cells of the pancreas [24,25]. In
vitro studies have shown that alloxan is selectively toxic to
pancreatic beta cells, leading to the induction of cell
necrosis [26]. The cytotoxic action of alloxan is mediated
by reactive oxygen species, with a simultaneous massive
increase in cytosolic calcium concentration, leading to a
rapid destruction of beta cells [27].
We showed that the aqueous extract from C. sicyoides
(AECS, 100 and 200 mg/kg), administered orally for 7
days, produced significant decreases in plasma glucose in
the model of alloxan-induced diabetes in rats, by compar-
ing the results before and after the AECS treatment. A
similar effect was observed after a shorter (4 days) treat-
ment with the higher dose of AECS (200 mg/kg). How-
ever, AECS had no effect on glycemia in normal rats.
Besides, no significant decrease was detected in diabetic
animals administered with distilled water, for the same
period of time (controls). Although the alloxan group
(controls) presented a dramatic body weight reduction,
weight losses were lower in the alloxan plus AECS-treated
group, indicating another potential benefit of AECS.
Our findings that the extract of C. sicyoides reduces the gly-
cemia of alloxan-induced diabetic rats, but had no effect
on that of normal rats, are in agreement with a very recent
work [16]. These authors also showed that the leaf decoc-
tion from C. sicyoides significantly reduced the intake of
both food and fluid, and the volume of urine excreted, as
well as the levels of blood glucose, urinary glucose and
urinary urea, as compared to controls. Others [17]
showed that, after oral administration, the leaf extract
from C. sicyoides presented a potential hypoglycemic activ-
ity in hereditary diabetic mice, normal rats and rats with
streptozotocin-induced diabetes. The authors showed that
the extract, administered for 4 weeks, significantly low-
ered the mean plasma glucose level of mice, under feeding
Table 4: Body weights of alloxan-induced diabetic rats before and after treatment with the aqueous extract from Cissus sicyoides (AECS)
Group Body weight (g) % Death
Before After
Control 218.3 ± 4.30 (15) 169.3 ± 5.41 (10)* 33
AECS
100 mg/kg, p.o. 288.8 ± 6.63 (15) 264.3 ± 14.45 (8) 47
200 mg/kg, p.o. 243.7 ± 7.63 (15) 208.7 ± 9.61 (7) 53
Values are means ± SEM. Animals were administered daily with distilled water (controls) or AECS, for 7 days (see Methods, for details). *p < 0.05, 
as compared to the same group, 48 h after the alloxan injection (ANOVA and Tukey as the post hoc test).
Table 5: Biochemical parameters determined in normal rats 
administered daily with the aqueous extract from Cissus sicyoides 
(AECS)
Parameter Result Reference Values
Glucose (mg/dL) 88.5 ± 1.55 63.3 – 86.4
Total cholesterol (mg/dL) 54.3 ± 2.74 51.1 – 71.5
Triglycerides (mg/dL) 54.2 ± 0.87 42.9 – 64.4
AST (IU/L) 78.0 ± 4.46 72.6 – 105.8
ALT (IU/L) 29.4 ± 1.20 19.7 – 31.7
Values are means ± SEM of 8 normal rats treated daily with 100 mg/
kg, p.o., of AECS, for 7 days. In Reference Values, the intervals are 
means ± SD of 22 animals (male Wistar rats), from the Animal House 
of the Faculty of Medicine of Juazeiro do Norte – FMJ.
Table 6: Phytochemical profile of the fresh leaves from Cissus 
sicyoides








For the phytochemical profile, specific reactions for chemical groups 
or thin layer chromatography (TLC) were performed. + = presence; - 
= absence.BMC Pharmacology 2004, 4 http://www.biomedcentral.com/1471-2210/4/9
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conditions. Besides, a single oral administration signifi-
cantly lowered the plasma glucose level, 1 h after sucrose
loading, in normal rats and rats with streptozotocin-
induced diabetes.
However, Beltrame et al., 2001 [12] failed to show any
anti-diabetic activity in the hydroalcoholic extract
obtained from the leaves of C. sicyoides, which instead
intensified the decreased glucose tolerance promoted by
dexamethasone, in rats. It is worthwhile to point out that
the plant is popularly used as a decoction, which is similar
to the aqueous extract used in the present work. Active
principles responsible for the hypoglycemic activity pre-
sented by C. sicyoides are possibly better extracted by aque-
ous and more polar solvents.
We found that the aqueous extract is rich in carbohydrate
type compounds, which are easily precipitated by ethanol
(results not shown). Besides, recently [13] a new cou-
marin glycoside was obtained from the aerial parts of C.
sicyoides. Glycosides are sugar derivatives, and an over-
whelming number of glycosides occur in nature, mainly
in plants, and such compounds have received much atten-
tion for possessing a variety of biological activities. Thus,
flour prepared from C. rotundifolia was shown to contain
significant amounts of non-starch polysaccharides [28],
the major fraction of which was water-soluble. These
authors verified that, in humans, the species elicited sig-
nificant reductions in plasma glucose levels, at post-pran-
dial time points and for the area-under-the-curve (AUC)
values. Significant reductions in plasma insulin levels, at
various post-prandial time points and for AUC values,
were also seen after C. rotundifolia administration. Water-
soluble non-starch polysaccharides are certainly one of
the components responsible for the glucose and insulin
lowering effects.
Although, in the present work, we showed no changes in
total cholesterol levels, a significant decrease was
observed in plasma triglyceride levels in the alloxan-
induced diabetic rats, after 4 and 7-day treatments with
AECS administered orally. On the other hand, another
work [16] did not find any alteration in lipid metabolism,
nor in levels of hepatic glycogen in streptozotocin-dia-
betic rats, after C. sicyoides treatment. According to them,
these results indicate that the mechanism responsible for
the improvement in carbohydrate metabolism, observed
in animals treated with C. sicyoides decoction, does not
involve inhibition of glycogenolysis and/or stimulation of
glycogenesis.
We also measured plasma levels of AST and ALT, hepatic
enzyme markers, and showed that these enzyme levels
were significantly increased after AECS treatment. How-
ever, these effects were also observed in controls and,
under both conditions, the values are in the range of those
shown by our normal control rats. Elevated activities of
serum aminotransferases are a common sign of liver dis-
ease, and are more frequently observed among people
with diabetes, than in the general population. Further-
more, diabetic complications such as limited joint mobil-
ity, retinopathy and neuropathy are associated with liver
enzyme activities, independently of alcohol consump-
tion, body mass index, and metabolic control of diabetes
[20]. Besides, it has been shown that the alloxan injection
causes a significant increase in the activity of several
enzymes, such as beta-glucuronidase, N-acetyl-beta-glu-
cosaminidase, lysosomal acid phosphatase, leucine ami-
nopeptidase, and cathepsin D [29]. Moreover, the
activities of the aspartate aminotransferase (AST) and
alanine aminotransferase (ALT) enzymes, among others,
have been used as indicators of tissue toxicity in experi-
mental diabetes. For instance, Mori et al., 2003 [30]
reported that levels of AST, ALT and alkaline phosphatase
(ALP) were higher in streptozotocin-induced diabetic rats,
over a 53-day period.
The duration of the alloxan-induced diabetic state is still a
matter of concern. An earlier work [31] showed that
alloxan-induced diabetes of 4-day duration produced
metabolite changes in the brain, compatible with severe
reduction of cerebral metabolism and reduced phosphof-
ructokinase activity. Alloxan-treated animals were also
severely dehydrated. A more recent work [32] showed dis-
ease-related abnormalities, such as ATPase activities in sci-
atic nerves, from rats with alloxan-induced diabetes of
various durations (2 weeks up to 6 months). Others
observed high glucose levels even after 2 weeks of alloxan
injection [33]. Under the conditions of the present inves-
tigation, diabetes was well maintained up to the 7th-day
treatment with AECS, which began 48 h after a single
alloxan injection.
Levels of glucose, insulin, triglycerides and total choles-
terol were also shown to increase in experimental models
of chemically-induced diabetes, including that with
alloxan. A recent work [34] reported the reversibility of
the diabetic state, 12 days after the alloxan injection, as
demonstrated by the reduction of glucose and triglyceride
concentrations, and a positive reaction of the anti-insulin
antibodies in the pancreatic tissue. In the present investi-
gation, we followed the hepatic enzymes and lipid profile,
for 4 and 7 days, when the diabetic state was still well
maintained.
AECS administration to normal animals caused no
changes in any of the measured parameters, similarly to
results observed by others [16]. Their data and ours sug-
gest that the mode of action of AECS in diabetic animals
does not resemble those of sulfonyl ureas or insulin. ItBMC Pharmacology 2004, 4 http://www.biomedcentral.com/1471-2210/4/9
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may, however, act in a similar way to biguanides, via the
inhibition of gluconeogenesis.
Conclusions
In conclusion, we showed anti-diabetic and anti-lipemic
effects of the aqueous extract prepared from the fresh
leaves of C. sicyoides. The plant leaves are rich in polysac-
charide type compounds, and some of the effects
observed with the AECS were also demonstrated with the
carbohydrate fraction. Our results suggest that, at least in
part, AECS effects are due to this plant constituents.
Methods
Plant material and preparation of the aqueous extract
The plant was collected at the city of Barbalha, state of
Ceará, Brazil, and identified by Prof. A. Fernandes from
the Biology Department, of the Federal University of
Ceará (UFC). The voucher (No. 32.240-EAC) is deposited
at the Prisco Bezerra Herbarium, of the UFC. Three hun-
dred grams of fresh leaves from C. sicyoides were blended
with approximately 2 L of distilled water, in order to pre-
pare an aqueous extract. The extract was heated for about
2 h at 60°C, filtered in a double layer of gauze, and
reduced at 60°C to half of its original volume. A one mil-
liliter sample was completely evaporated in the oven, and
the solid residue was weighted, giving a final concentra-
tion of 20 to 30 mg per mL. The extract was kept at -20°C
until use.
Animals
Male Wistar rats (250–300 g) from the Animal House of
the Faculty of Medicine of Juazeiro do Norte (FMJ) were
used. Animals were maintained in plastic cages and 12 h
light/dark cycle, with free access to food and water. Exper-
iments were performed according to the Guide for the care
and use of laboratory animals, from the US Department of
Health and Human Services.
Experimental protocol
Diabetes was induced by the intravenous administration
of alloxan (60 mg/kg), after anesthesia with ethyl ether.
Forty-eight hours later, the blood (1 mL) was collected
from the orbital sinus into tubes containing separator gel
(from Vacuette, Brazil). The serum was separated by cen-
trifugation at 3,500 rpm for 10 min, and immediately
used for biochemical assays. Only animals presenting gly-
cemic levels equal to or above 200 mg/dL were submitted
to treatments, which consisted of a daily administration
of the AECS (100 and 200 mg/kg, p.o.) or an equivalent
volume of distilled water (controls), for 4 or 7 days. The
oral treatments (by gavage) of all groups were carried out
at the same time (in the morning) and under the same
conditions. One hour after the last administration, the
blood was collected again for biochemical measurements.
In another set of experiments, non-diabetic normal rats
were administered daily with AECS (100 mg/kg, p.o.) for
7 days and, 1 h after the last administration, the blood was
collected for biochemical measurements as described
above.
Biochemical measurements
Glucose was determined according to a previously
described method [21]. Determinations of ALT and AST
were carried out by methods described by Bergmeyer et
al., 1978 [22], and triglycerides and cholesterol were
measured by standard enzymatic methods with a spectro-
photometer Selectra II model, from Winner. The phyto-
chemical profile was performed as described by Costa,
1977 [23], through identification reactions based on the
chemical group to be determined or by thin layer
chromatography.
Statistical analysis
Results were expressed as means ± SEM. Data were ana-
lyzed with One-way ANOVA for the comparison between
groups, followed by Tukey as a post hoc test. The signifi-
cance level was set at p < 0.05.
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